Sowell Financial Services’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,973
Closed -$382K 1192
2026
Q1
$382K Buy
3,973
+45
+1% +$4.5K 0.01% 734
2025
Q4
$382K Buy
+3,928
New +$337K 0.01% 736
2020
Q1
Sell
-11
Closed 2555
2019
Q4
$0 Sell
11
-11
-50% -$257 ﹤0.01% 2590
2019
Q3
$0 Buy
+22
New +$449 ﹤0.01% 2418
2017
Q1
Sell
-3,348
Closed -$29K 411
2016
Q4
$29K Buy
+3,348
New +$36K 0.01% 389

Other funds holding IRMD

Sowell Financial Services's IRMD Position: Q2 2026 in Review

Sowell Financial Services sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 3,973 shares — an estimated $382K sold.

Sowell Financial Services first reported a position in IRMD in Q4 2016 and held it in 5 quarters. The position peaked at $382K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Sowell Financial Services reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • Sowell Financial Services sold 3,973 iRadimed shares in Q2 2026, an estimated $382K.
  • Sowell Financial Services first reported a position in iRadimed in Q4 2016 and held it in 5 quarters.
  • Sowell Financial Services's iRadimed position peaked at $382K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.